For the broader GLP-1 market, Canadas first generic semaglutide approval shows how the access debate is shifting from shortage-era workarounds to formal generic competition, with each countrys patent rules determining the pace
Research and Development Despite these challenges, the benefits of GLP-1 receptor agonistssuch as improved blood sugar control and weight managementare substantial, and research continues to focus on improving these therapies: Improving Formulations: Ongoing research aims to develop new formulations that might reduce side effects or offer easier methods of administration
Current clinical-trial and FDA materials provide additional topical, compounding, and regulatory context [9] [10] [11] [12]
It's been used for longer, which means we have more long-term data about how it performs and what side effects to expect
Its not, emphasizes Bruno
Mohta, to maintain the benefits you achieved over the past year, it is crucial to continue using tretinoin as part of your long-term skincare routine